Regeneron Pharma Q2 Results Top Estimates - Update

Regeneron Pharma Expects Q4 Results To Include $24 Mln In Acquired In-process R&D Charge

Regeneron Pharmaceuticals, Inc. (REGN) said Monday it currently expects that its financial results for the second quarter 2024 will include an acquired in-process research and development charge of approximately $24 million on a pre-tax basis.

RTTNews | 183 dni temu

Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

RTTNews | 193 dni temu

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.

RTTNews | 340 dni temu

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.

RTTNews | 921 dni temu

Dollar Rises Against Major Counterparts On Strong Economic Data

The U.S. dollar firmed against its major counterparts on Tuesday on bets the Federal Reserve will slowdown its rate cut moves after data showed an improvement in the nation's service sector activity in the month of December. Higher bond yields contributed as well to greenback's rise.

RTTNews | 5g 21 minut temu

Indian Economy To Expand 6.4% In FY25, Weakest In 4 Years: Govt Estimate

India's economy is set to grow at the slowest pace in 4 years in the fiscal year 2024-25, initial estimates from the government showed on Tuesday. Gross domestic product is expected to grow 6.4 percent in the financial year ending March 31 following an 8.2 percent expansion in the previous fiscal.

RTTNews | 6g 51 minut temu

Swiss Market Ends On Strong Note After Inflation Data

The Switzerland market closed on a strong note on Tuesday with stocks shrugging off early weakness and gaining in strength as the day progressed. Data showing a slowdown in consumer price inflation aided sentiment.

RTTNews | 8g 21 minut temu

European Stocks Close Higher As Markets React To Economic Data

European stocks closed mostly higher on Tuesday despite struggling a bit early on in the session, as investors digested a slew of regional economic data and continued to bet on more monetary easing by central banks in the first quarter of 2025.

RTTNews | 8g 37 minut temu

EURUSD	1.03405	GBPUSD	1.24755	AUDUSD	0.62301
USDJPY	158.001	USDCAD	1.43648	USDCHF	0.90928